| Predicate |
Object |
| classificationCPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K47-34 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K36-35
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K36-752
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K36-537
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-198
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K36-53
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-737
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K36-258
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K36-28
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K47-10
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K36-185
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-7008
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-0014 |
| classificationIPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K47-34 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-7008
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-198
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K47-10
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K36-537
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K36-35
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K36-53
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K36-258
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K36-28
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K36-185
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K9-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-737 |
| filingDate |
2002-04-30-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| grantDate |
2004-05-04-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_6f20c6dc9a6e6d690043e6d0a6d2b255 |
| publicationDate |
2004-05-04-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
US-6730331-B1 |
| titleOfInvention |
Topically applied creatine containing composition |
| abstract |
The present invention is a stable topical creatine application suitable for absorption directly through the skin into the underlying muscle without traveling through the blood system for the purpose of increasing muscle energy. It is created by combining creatine with phosphoric acid in a cosmetically elegant vehicle suitable for topical use. Chondroitin sulfate and glucosamine can also be added. Topical creatine avoids the side effects of oral creatine supplements. |
| isCitedBy |
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2007116653-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2005040475-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2002049253-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-8263053-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-7186754-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-7226947-B1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-11633451-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2017173236-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2011224174-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2009007660-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2006040122-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-9833427-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-10206897-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2005266225-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2009105196-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2005186195-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2005186194-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2005227996-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2006194759-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2006240236-A1 |
| priorityDate |
2000-11-27-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |